Princeton Capital Management LLC Acquires Shares of 407 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Princeton Capital Management LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, HoldingsChannel.com reports. The fund bought 407 shares of the medical equipment provider’s stock, valued at approximately $212,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $31,000. Finally, Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $36,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ISRG. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Truist Financial reduced their target price on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research report on Monday, March 17th. BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Evercore ISI raised their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Up 3.3 %

Shares of NASDAQ ISRG opened at $508.58 on Tuesday. The firm has a market cap of $181.15 billion, a P/E ratio of 79.34, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The business’s 50 day moving average price is $561.62 and its 200 day moving average price is $532.25.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.